These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 8730290)
21. VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality. Bender BU; Eng C; Olschewski M; Berger DP; Laubenberger J; Altehöfer C; Kirste G; Orszagh M; van Velthoven V; Miosczka H; Schmidt D; Neumann HP J Med Genet; 2001 Aug; 38(8):508-14. PubMed ID: 11483638 [TBL] [Abstract][Full Text] [Related]
22. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred. Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570 [TBL] [Abstract][Full Text] [Related]
23. Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Clinical Research Group for VHL in Japan. Hum Mol Genet; 1995 Dec; 4(12):2233-7. PubMed ID: 8634692 [TBL] [Abstract][Full Text] [Related]
24. [Von Hippel-Lindau disease]. Shuin T; Ashida S; Yao M; Kanno H Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322 [TBL] [Abstract][Full Text] [Related]
25. Von Hippel-Lindau disease. Maher ER Curr Mol Med; 2004 Dec; 4(8):833-42. PubMed ID: 15579030 [TBL] [Abstract][Full Text] [Related]
26. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Webster AR; Richards FM; MacRonald FE; Moore AT; Maher ER Am J Hum Genet; 1998 Oct; 63(4):1025-35. PubMed ID: 9758595 [TBL] [Abstract][Full Text] [Related]
27. Somatic mosaicism in von Hippel-Lindau Disease. Murgia A; Martella M; Vinanzi C; Polli R; Perilongo G; Opocher G Hum Mutat; 2000 Jan; 15(1):114. PubMed ID: 10612832 [TBL] [Abstract][Full Text] [Related]
28. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors. Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513 [TBL] [Abstract][Full Text] [Related]
29. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma. Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095 [TBL] [Abstract][Full Text] [Related]
30. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170 [TBL] [Abstract][Full Text] [Related]
31. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma. Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424 [TBL] [Abstract][Full Text] [Related]
32. Von Hippel-Lindau disease and sporadic renal cell carcinoma. Zbar B Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521 [TBL] [Abstract][Full Text] [Related]
33. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612 [TBL] [Abstract][Full Text] [Related]